CN Patent

CN101547904A — (αS，βR)-6-溴-α-[2-(二甲胺基)乙基]-2-甲氧基-α-1-萘基-β-苯基-3-喹啉乙醇的富马酸盐

Assigned to Janssen Pharmaceutica NV · Expires 2009-09-30 · 17y expired

What this patent protects

本发明涉及(αS，βR)－6－溴－α－[2－(二甲胺基)乙基]－2－甲氧基－α－1－萘基－β－苯基－3－喹啉乙醇的富马酸盐，包含作为活性成分的该盐类的医药组合物以及其制备方法。

USPTO Abstract

本发明涉及(αS，βR)－6－溴－α－[2－(二甲胺基)乙基]－2－甲氧基－α－1－萘基－β－苯基－3－喹啉乙醇的富马酸盐，包含作为活性成分的该盐类的医药组合物以及其制备方法。

Drugs covered by this patent

bedaquiline-fumarate (BEDAQUILINE FUMARATE)

Patent Metadata

Patent number: CN101547904A
Jurisdiction: CN
Classification: —
Expires: 2009-09-30
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Pharmaceutica NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.